Financial Analysis: Madrigal Pharmaceuticals Inc (MDGL)’s Ratios Unveil Key Insights

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Madrigal Pharmaceuticals Inc’s stock clocked out at $315.15, down -7.05% from its previous closing price of $339.04. In other words, the price has decreased by -$7.05 from its previous closing price. On the day, 0.48 million shares were traded. MDGL stock price reached its highest trading level at $342.58 during the session, while it also had its lowest trading level at $314.02.

Ratios:

To gain a deeper understanding of MDGL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.93 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.

On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $382.

On April 22, 2024, BofA Securities started tracking the stock assigning a Underperform rating and target price of $150.BofA Securities initiated its Underperform rating on April 22, 2024, with a $150 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 07 ’24 when Levy Richard S sold 5,000 shares for $350.00 per share. The transaction valued at 1,750,000 led to the insider holds 11,012 shares of the business.

RICHARD S LEVY bought 5,000 shares of MDGL for $1,691,100 on Nov 07 ’24. On Nov 01 ’24, another insider, Levy Richard S, who serves as the Director of the company, sold 5,000 shares for $300.94 each. As a result, the insider received 1,504,703 and left with 11,012 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDGL now has a Market Capitalization of 6873547264 and an Enterprise Value of 5994063872. For the stock, the TTM Price-to-Sale (P/S) ratio is 89.49 while its Price-to-Book (P/B) ratio in mrq is 8.84. Its current Enterprise Value per Revenue stands at 78.034 whereas that against EBITDA is -10.954.

Stock Price History:

Over the past 52 weeks, MDGL has reached a high of $368.29, while it has fallen to a 52-week low of $135.15. The 50-Day Moving Average of the stock is 30.33%, while the 200-Day Moving Average is calculated to be 28.38%.

Shares Statistics:

It appears that MDGL traded 347.48K shares on average per day over the past three months and 915830 shares per day over the past ten days. A total of 19.88M shares are outstanding, with a floating share count of 18.20M. Insiders hold about 16.57% of the company’s shares, while institutions hold 102.08% stake in the company. Shares short for MDGL as of 1730332800 were 4532914 with a Short Ratio of 13.04, compared to 1727654400 on 3862050. Therefore, it implies a Short% of Shares Outstanding of 4532914 and a Short% of Float of 29.830000000000002.

Most Popular